# ASCs in Recently Diagnosed Non-ischemic Heart Failure

> **NCT06840275** · PHASE2 · WITHDRAWN · sponsor: **Cell to Cure ApS**

## Conditions studied

- Non-Ischemic Heart Failure
- Reduced Ejection Fraction Heart Failure

## Interventions

- **DRUG:** Allogeneic adipose tissue-derived mesenchymal stem cells
- **OTHER:** Cryostor CS10

## Key facts

- **NCT ID:** NCT06840275
- **Lead sponsor:** Cell to Cure ApS
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2026-03-01
- **Primary completion:** 2028-09-01
- **Final completion:** 2028-09-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Due to changes in company structure and investment the trial will not be initiated.
- **Last updated:** 2026-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06840275

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06840275, "ASCs in Recently Diagnosed Non-ischemic Heart Failure". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06840275. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*